Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography.
BACKGROUND
Although many patients with papillary thyroid carcinoma (PTC) display associated cervical lymph node metastases (LNM), the optimal extent of lymph node dissection (LND) remains a matter of debate. Since 1993, we have performed cervical LND based on the preoperative suspicion of LNM by ultrasonography (US). We prospectively analyzed the outcomes of our "selective" LND to determine when prophylactic lateral neck dissection is advisable.


METHODS
Prospective analysis was conducted for 361 consecutive patients with PTC who received initial surgery between 1993 and 2001. Mean duration of follow-up was 8.1 years. Dissection of the central compartment only was performed for patients with LNM in the central zone only and for patients with no LNM detected by US (Group A). Modified radical lateral neck dissection (MND; combined with central compartment dissection) was performed for patients diagnosed with lateral neck LNM (Group B).


RESULTS
Pathological LNM was found in 136 of 231 patients in Group A (59%). As for the accuracy of US diagnosis, positive predictive value was 82%. Nodal recurrences, occurring all in the lateral cervical region associated with one case of contralateral paratracheal region, was seen in 18 patients (8%) and 10-year nodal disease-free survival was 91%. Univariate analysis revealed true positive diagnosis by US, large primary tumor (> or = 4 cm), primary tumor located in the upper part of the thyroid lobe, presence of distant metastasis, extrathyroidal invasion of the primary tumor, and a poorly differentiated component of the primary tumor as significant risk factors for nodal recurrence. Among the risk factors that could be diagnosed preoperatively, distant metastasis (risk ratio, 46; p = 0.01) and large primary tumor (risk ratio, 3.6; p = 0.03) were the most important factors under multivariate analysis. Of the other 130 patients in Group B, only 3 patients had no pathological LNM (positive predictive value, 98%). Twenty-six patients (20%) developed nodal recurrence, with a 10-year nodal disease-free survival of 76%. Age (50 years or older), large nodal metastasis (> or = 3 cm), extrathyroidal invasion, and higher serum thyroglobulin level (> or =320 ng/ml) represented significant factors for nodal recurrence.


CONCLUSIONS
When preoperative US shows no LNM or indicates only LNM in the central compartment, dissection of the central compartment alone offers a sufficient alternative to routine prophylactic MND. However, patients with PTC demonstrating large primary tumor and/or distant metastasis were high-risk for recurrence in the lateral cervical compartment. We recommend prophylactic MND to reduce nodal recurrence for those patients.
Sugitani
Iwao
I
Division of Head and Neck, Cancer Institute Hospital, 3-10-6, Ariake, Tokyo, 135-8550, Japan. isugitani@jfcr.or.jp
Fujimoto
Yoshihide
Y
Yamada
Keiko
K
Yamamoto
Noriko
N
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002291:Carcinoma, Papillary / Q000000981:diagnostic imaging* / Q000473:pathology* / Q000601:surgery; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D037981:Neck Dissection / Q000379:methods*; D011237:Predictive Value of Tests; D011300:Preoperative Care; D011446:Prospective Studies; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology* / Q000601:surgery; D013965:Thyroidectomy; D016896:Treatment Outcome; D014463:Ultrasonography; D055815:Young Adult
World J Surg. 2005 Jul;29(7):917-20
15951927
Surgery. 1993 Dec;114(6):1050-7; discussion 1057-8
8256208
Thyroid. 1995 Feb;5(1):25-8
7787429
Cancer. 1998 Jan 15;82(2):375-88
9445196
Am J Med. 1994 Nov;97(5):418-28
7977430
Ann Surg Oncol. 2007 Jun;14(6):1790-800
17342568
N Engl J Med. 1993 Feb 25;328(8):553-9
8426623
Eur J Surg Suppl. 2003 Jul;(588):46-50
15200043
Surgery. 2004 Feb;135(2):139-48
14739848
World J Surg. 2007 Nov;31(11):2085-91
17885787
Cancer. 1997 Dec 15;80(12):2268-72
9404704
Surgery. 1995 Dec;118(6):1131-6; discussion 1136-8
7491533
Endocr Pract. 2001 May-Jun;7(3):202-20
11430305
J Clin Endocrinol Metab. 2007 Sep;92(9):3590-4
17609301
World J Surg. 2007 Oct;31(10):1954-9
17687598
World J Surg. 1996 Sep;20(7):860-6; discussion 866
8678963
Cancer. 1998 Sep 1;83(5):844-7
9731884
Surgery. 2008 Jan;143(1):35-42
18154931
Langenbecks Arch Surg. 2007 Jul;392(4):417-22
17562092
World J Surg. 2002 Jan;26(1):22-8
11898029
Arch Otolaryngol Head Neck Surg. 2002 Jul;128(7):751-8
12117328
Arch Surg. 1998 Mar;133(3):276-80
9517740
Endocr J. 2006 Dec;53(6):829-39
17001109